tsRNA-5008a modulates SLC7A11, a marker associated with ferroptosis, through AGO2 targeting, thereby increasing fibrosis and ferroptosis in myocardial tissue, which in turn exacerbates the progression of atrial fibrillation (AF) [68]. Here, AGO2 is linked to atrial fibrillation.